Affiliations: Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Correspondence:
[*]
Corresponding author: Brian H. Eisner, MD, Department of Urology, GRB 1102, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. Tel.: +1 617 726 2797; Fax: +1 617 726 6131; E-mail: beisner@partners.org.
Abstract: Lymphotrophic nanoparticle enhanced magnetic resonance imaging is a promising new diagnostic modality for lymph node staging in genitourinary malignancies. The technique utilizes ultrasmall superparamagnetic iron oxide particles to provide detailed characterization of lymph nodes for detection of metastatic disease. Early results have are promising for bladder, penile, prostate, and testicular cancer. This review provides an overview of the current state of lymphotrophic enhanced magnetic resonance imaging in genitourinary cancers.
